A detailed history of Aequim Alternative Investments LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Aequim Alternative Investments LP holds 25,900 shares of JAZZ stock, worth $3.15 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
25,900
Previous 25,900 -0.0%
Holding current value
$3.15 Million
Previous $2.76 Million 4.41%
% of portfolio
0.97%
Previous 0.95%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $2.21 Million - $2.62 Million
19,300 Added 292.42%
25,900 $3.19 Million
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $4.5 Million - $5.28 Million
-32,000 Reduced 82.9%
6,600 $1.09 Million
Q4 2020

Feb 10, 2021

BUY
$140.71 - $165.05 $4.5 Million - $5.28 Million
32,000 Added 484.85%
38,600 $1.26 Million
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $631,488 - $804,408
6,600 New
6,600 $728,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.62B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Aequim Alternative Investments LP Portfolio

Follow Aequim Alternative Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aequim Alternative Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Aequim Alternative Investments LP with notifications on news.